| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |